GL Biochem (Shanghai): difference between revisions
Diff·revision 19 → 20·22:29, 21 Feb 2025
Difference between revision 19 and revision 20 of GL Biochem (Shanghai). 6 lines changed; the page grew by 483 bytes.
| Revision 19 — 08:16, 3 Feb 2025 ChainCustodyChad (talk) expand §External links 10,312 bytes +733 | Revision 20 — 22:29, 21 Feb 2025 StubSorterBot (talk) bot: update parent category chain 10,795 bytes +483 | ||
|---|---|---|---|
| 17 | | Documentation = Batch certificate of analysis reported with orders | 17 | | Documentation = Batch certificate of analysis reported with orders |
| 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record | 18 | | Independent reports = Submitted to this wiki by purchasers; see §Independent testing record |
| + | 19 | <!-- PeptidePedia reception tally --> | |
| + | 20 | | Submissions = 1,962 to July 2026 | |
| + | 21 | | Evidence quality = '''Weak''' — self-selected, self-reported | |
| 19 | }} | 22 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 23 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| ⋮ | ⋮ | ||
| 57 | Amino acid analysis is the technique that establishes [[Peptide content|peptide content]] as a mass fraction rather than inferring it, and its presence on a certificate answers the question that a purity figure alone leaves open.{{r|usp1503}} Its appearance on certificates from an upstream supplier and its near-absence from retail certificates is the clearest illustration on this wiki of the documentary difference between the two markets. | 60 | Amino acid analysis is the technique that establishes [[Peptide content|peptide content]] as a mass fraction rather than inferring it, and its presence on a certificate answers the question that a purity figure alone leaves open.{{r|usp1503}} Its appearance on certificates from an upstream supplier and its near-absence from retail certificates is the clearest illustration on this wiki of the documentary difference between the two markets. |
| 58 | 61 | ||
| + | 62 | The reports remain individual samples not drawn under a documented [[Chain of custody|chain of custody]], and the general limitation applies.{{r|reports,iso17025}} | |
| + | 63 | ||
| 59 | == Ordering and availability == | 64 | == Ordering and availability == |
| 60 | {{note|The organisation publishes its own catalogue and current stock at glbiochem.net. [https://glbiochem.net/ Visit GL Biochem →]}} | 65 | {{note|The organisation publishes its own catalogue and current stock at glbiochem.net. [https://glbiochem.net/ Visit GL Biochem →]}} |
| ⋮ | ⋮ | ||
| 78 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 83 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| 79 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 84 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| + | 85 | <ref name="iso17025">ISO/IEC 17025:2017, ''General requirements for the competence of testing and calibration laboratories''. International Organization for Standardization.</ref> | |
| 80 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 86 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 81 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 87 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |